Medical complications following splenectomy

Journal of Visceral Surgery

Volumn 153, Issue 4, 2016, Pages 277-286

  Buzele R ^a,b   Barbier, L ^a,c   Sauvanet, A ^a   Fantin, B ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hopital Yves Le Foll   (France)

^c SERVICE DE DERMATOLOGIE   (France)

Author keywords

Cancer risk; Infection; Septicemia; Splenectomy; Thromboembolic complications; Vaccination

Indexed keywords

HUMAN; OUTCOME ASSESSMENT; PATIENT EDUCATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK FACTOR; SPLENECTOMY;

HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SPLENECTOMY;

EID: 85020295969     PISSN: 18787886     EISSN: 18787878     Source Type: Journal    
DOI: 10.1016/j.jviscsurg.2016.04.013     Document Type: Short Survey

References (56)

1. Mellemkjoer, L., Olsen, J.H., Linet, M.S., Gridley, G., McLaughlin, J.K., Cancer risk after splenectomy. Cancer 75 (1995), 577–583.
2. Kristinsson, S.Y., Gridley, G., Hoover, R.N., Check, D., Landgren, O., Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica 99 (2014), 392–398.
3. Shen, J.G., Cheong, J.H., Hyung, W.J., Kim, J., Choi, S.H., Noh, S.H., Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg 192 (2006), 301–305.
4. Bisharat, N., Omari, H., Lavi, I., Raz, R., Risk of infection and death among post-splenectomy patients. J Infect 43 (2001), 182–186.
5. Davidson, R.N., Wall, R.A., Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 7 (2001), 657–660.
6. Schwartz, P.E., Sterioff, S., Mucha, P., Melton, L.J., Offord, K.P., Post-splenectomy sepsis and mortality in adults. JAMA 248 (1982), 2279–2283.
7. Di Sabatino, A., Carsetti, R., Corazza, G.R., Post-splenectomy and hyposplenic states. Lancet 378 (2011), 86–97.
8. Toutouzas, K.G., Velmahos, G.C., Kaminski, A., Chan, L., Demetriades, D., Leukocytosis after posttraumatic splenectomy: a physiologic event or sign of sepsis?. Arch Surg 137 (2002), 924–928.
9. Kruetzmann, S., Rosado, M.M., Weber, H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197 (2003), 939–945.
10. Rubin, L.G., Schaffner, W., Clinical practice. Care of the asplenic patient. N Engl J Med 371 (2014), 349–356.
11. Dahyot-Fizelier, C., Debaene, B., Mimoz, O., [Management of infection risk in asplenic patients]. Ann Fr Anesth Reanim 32 (2013), 251–256.
12. Shepard, C.W., Daneshvar, M.I., Kaiser, R.M., et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis 38 (2004), 799–804.
13. Cherif, H., Landgren, O., Konradsen, H.B., Kalin, M., Björkholm, M., Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 24 (2006), 75–81.
14. El-Alfy, M.S., El-Sayed, M.H., Overwhelming post-splenectomy infection: is quality of patient knowledge enough for prevention?. Hematol J 5 (2004), 77–80.
15. Waghorn, D.J., Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 54 (2001), 214–218.
16. Holdsworth, R.J., Irving, A.D., Cuschieri, A., Post-splenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 78 (1991), 1031–1038.
17. Ellison, E.C., Fabri, P.J., Complications of splenectomy. Etiology, prevention, and management. Surg Clin North Am 63 (1983), 1313–1330.
18. Wiseman, J., Brown, C.V., Weng, J., Salim, A., Rhee, P., Demetriades, D., Splenectomy for trauma increases the rate of early postoperative infections. Am Surg 72 (2006), 947–950.
19. Weng, J., Brown, C.V., Rhee, P., et al. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma 59 (2005), 1076–1080.
20. Styrt, B., Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 88:5N (1990), 33N–42N.
21. Vaccination des personnes immunodéprimées ou aspléniques. Recommandations actualisées. Internet. Cité 24 juill 2015. Disponible sur : http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=504.
22. Coignard-Biehler, H., Lanternier, F., Hot, A., et al. Adherence to preventive measures after splenectomy in the hospital setting and in the community. J Infect Public Health 4 (2011), 187–194.
23. Adamkiewicz, T.V., Silk, B.J., Howgate, J., et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 121 (2008), 562–569.
24. Halasa, N.B., Shankar, S.M., Talbot, T.R., et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 44 (2007), 1428–1433.
25. Société française d'anesthésie et de réanimation, [Antibioprophylaxis in surgery and interventional medicine (adult patients). Actualization 2010]. Ann Fr Anesth Reanim 30:2 (2011), 168–190, 10.1016/j.annfar.2010.05.012 [Epub 2011 Feb 15].
26. Gaston, M.H., Verter, J.I., Woods, G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314 (1986), 1593–1599.
27. Steele, R.W., Warrier, R., Unkel, P.J., et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J Pediatr 128 (1996), 531–535.
28. Corbett, S.M., Rebuck, J.A., Rogers, F.B., et al. Time lapse and co-morbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy. J Trauma 62 (2007), 397–403.
29. Wang, J., Jones, P., Cheng, A.C., Leder, K., Adherence to infection prevention measures in a statewide spleen registry. Med J Aust 200 (2014), 538–540.
30. Crary, S.E., Buchanan, G.R., Vascular complications after splenectomy for hematologic disorders. Blood 114 (2009), 2861–2868.
31. Watters, J.M., Sambasivan, C.N., Zink, K., et al. Splenectomy leads to a persistent hypercoagulable state after trauma. Am J Surg 199 (2010), 646–651.
32. Pommerening, M.J., Rahbar, E., Minei, K., et al. Splenectomy is associated with hypercoagulable thrombelastography values and increased risk of thromboembolism. Surgery 158 (2015), 618–626.
33. Tripodi, A., Mannucci, P.M., The coagulopathy of chronic liver disease. N Engl J Med 365 (2011), 147–156.
34. Danno, K., Ikeda, M., Sekimoto, M., et al. Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy. Surgery 145 (2009), 457–464.
35. Kawanaka, H., Akahoshi, T., Kinjo, N., et al. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension. Br J Surg 101 (2014), 1585–1593.
36. van't Riet, M., Burger, J.W., van Muiswinkel, J.M., Kazemier, G., Schipperus, M.R., Bonjer, H.J., Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 87 (2000), 1229–1233.
37. Romano, F., Caprotti, R., Conti, M., et al. Thrombosis of the splenoportal axis after splenectomy. Langenbecks Arch Surg 391 (2006), 483–488.
38. He, S., He, F., Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy. Int J Clin Exp Med 8:3 (2015), 4236–4242.
39. Krauth, M.-T., Lechner, K., Neugebauer, E.A.M., Pabinger, I., The postoperative splenic/portal vein thrombosis after splenectomy and its prevention – an unresolved issue. Haematologica 93 (2008), 1227–1232.
40. Stamou, K.M., Toutouzas, K.G., Kekis, P.B., et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg, 141, 2006, 663.
41. Kawanaka, H., Akahoshi, T., Kinjo, N., et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 251 (2010), 76–83.
42. Kinjo, N., Kawanaka, H., Akahoshi, T., et al. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 97 (2010), 910–916.
43. Li, M.-X., Zhang, X.-F., Liu, Z.-W., Lv, Y., Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 12 (2013), 512–519.
44. Ushitora, Y., Tashiro, H., Takahashi, S., et al. Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 28 (2011), 9–14.
45. Ikeda, M., Sekimoto, M., Takiguchi, S., et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241 (2005), 208–216.
46. Vecchio, R., Cacciola, E., Cacciola, R.R., Marchese, S., Intagliata, E., Portal vein thrombosis after laparoscopic and open splenectomy. J Laparoendosc Adv Surg Tech A 21 (2011), 71–75.
47. Wang, M., Zhang, M., Li, J., Zhou, J., Wu, Z., Peng, B., Risk factors of portal vein thrombosis in patients with beta thalassemia major after splenectomy: laparoscopic versus open procedure. Hepatogastroenterology 61 (2014), 48–54.
48. James, A.W., Rabl, C., Westphalen, A.C., Fogarty, P.F., Posselt, A.M., Campos, G.M., Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg 144 (2009), 520–526.
49. Hollingshead, M., Burke, C.T., Mauro, M.A., Weeks, S.M., Dixon, R.G., Jaques, P.F., Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 16 (2005), 651–661.
50. Manouchehri, N., Kaneva, P., Séguin, C., Artho, G.P., Feldman, L.S., Screening for thrombophilia does not identify patients at risk of portal or splenic vein thrombosis following laparoscopic splenectomy. Surg Endosc 30:5 (2016), 2119–2126, 10.1007/s00464-015-4476-3 [Epub 2015 Aug 26].
51. Qi, X., Bai, M., Guo, X., Fan, D., Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysis. Gastroenterol Res Pract, 2014, 2014, 292689.
52. Kawanaka, H., Akahoshi, T., Itoh, S., et al. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension. J Am Coll Surg 219 (2014), 865–874.
53. Samama, C.M., Gafsou, B., Jeandel, T., et al. Prévention de la maladie thromboembolique veineuse postopératoire. Actualisation 2011. Texte court. Ann Fr Anesth Reanim 30 (2011), 947–951.
54. Khan, P.N., Nair, R.J., Olivares, J., Tingle, L.E., Li, Z., Post-splenectomy reactive thrombocytosis. Proc (Bayl Univ Med Cent) 22 (2009), 9–12.
55. Haute Autorité de Santé et Agence Nationale du Médicament, Recommandations de bonne pratique : bon usage des antiplaquettaires. 2012 [Disponible à http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/12irp06_reco_agents_antiplaquettaires.pdf, accès le 15/11/2015].
56. Schwarz, R.E., Harrison, L.E., Conlon, K.C., Klimstra, D.S., Brennan, M.F., The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg 188 (1999), 516–521.